logo

Journal Articles (past 5 years)

Google Scholar
The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018 Sex Transm Dis. 2021 Apr 1;48(4):278-284 Chesson HW, Laprise JF, Brisson M, Martin D, Ekwueme DU, Markowitz LE.
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis MedRxiv Prem K, Choi YH, Bénard E, Burger EA, Hadley L, Laprise JF, Regan C, Drolet M, Sy S, Abbas K, Kim JJ, Brisson M, Jit M
Estimated prevalence and incidence of disease-associated HPV types among 15-59-year-olds in the United States Sex Transm Dis 2021; Volume Publish Ahead of Print - doi: 10.1097/OLQ.0000000000001356 Lewis RM, Laprise JF, Gargano JW, Unger ER, Querec TD, Chesson H, Brisson M, Markowitz LE
The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada – A mathematical modeling study of surveillance data Int J Inf Dis 2021;102:254-9. doi: 10.1016/j.ijid.2020.10.046 Godin A, Xia Y, Buckeridge DL, Mishra S, Douwes-Schultz D, Shen Y, Lavigne M, Drolet M, Schmidt AM, Brisson M, Maheu-Giroux M
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study The Lancet 2021;397(10272):398-408. doi: 10.1016/S0140-6736(20)32657-X Li X, Mukandavire C, Cucunubá ZM, Londono SE, Abbas K, Clapham HE, Jit M, Johnson HL, Papadopoulos T, Vynnycky E, Brisson M, et al.
The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018 Sexually Transmitted Diseases 2021;48(4):215-21 Chesson HW, Spicknall IH, Bingham A, Brisson M, Eppink ST, Farnham PG, Kreisel KM, Kumar S, Laprise JF, Peterman TA, Roberts H, Gift TL
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule Vaccine. Available online 13 January 2021. https://doi.org/10.1016/j.vaccine.2020.12.031 Whitworth HS, Schiller J, Markowitz LE, Jit M, Brisson M, Simpson E, Watson-Jones D
Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study Lancet Infect Dis 2021;21(1):116-126. doi: 10.1016/S1473-3099(20)30277-2 Greenaway C, Greenwald ZR, Akaberi A, Song S, Passos-Castilho AM, Chakra CNA, Palayew A, Alabdulkarim B, Platt R, Azoulay L, Brisson M, Quach C
Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study Lancet Glob Health 2020. doi: 10.1016/S2214-109X(20)30022-X. [Epub ahead of print] Abbas KM, van Zandvoort K, Brisson M, Jit M
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30068-4 Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, Smith MA, Laprise JF, Jit M, Alary M, Bray F, Fidarova E, Elsheikh F, Bloem PJN, Broutet N, Hutubessy R.
Mortality reductions and lives saved on the path to eliminating cervical cancer in 78 Low and Lower-Middle Income Countries: Comparative modelling of impact of achieving WHO targets for scaling up vaccination, cervical screening and cancer treatment services The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30157-4 Canfell K, Kim J, Brisson M, Keane A, Simms K, Caruana M, Burger E, Martin D, Nguyen DTN, Benard É, Sy S, Regan C, Laprise JF, Torode J, Smith M, Fidarova E, Trapani D, Ilbawi A, Broutet N, Hutubessy R
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study CMAJ August 26, 2019 191 (34) E932-E939; DOI: https://doi.org/10.1503/cmaj.190274 Drolet M, Zhou Z, Sauvageau C, DeWals P, Gilca V, Amini R, Bénard É, Brisson M
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control Papillomavirus research, ISSN: 2405-8521, Vol: 8 (2019), Page: 100184 Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M
Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States Ann Intern Med. 2019 Dec 10. doi: 10.7326/M19-1182. [Epub ahead of print] Laprise JF, Chesson HW, Markowitz LE, Drolet M, Martin D, Bénard É, Brisson M.
Guidelines for multi-model comparisons of the impact of infectious disease interventions BMC Med. 2019 Aug 19;17(1):163. doi: 10.1186/s12916-019-1403-9 den Boon S, Jit M, Brisson M, Medley G, Beutels P, White R, Flasche S, Hollingsworth TD, Garske T, Pitzer VE, Hoogendoorn M, Geffen O, Clark A, Kim J, Hutubessy R
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool Vaccine. 2019 Jul 18;37(31):4376-4381. doi: 10.1016/j.vaccine.2019.06.019. Epub 2019 Jun 24 Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr, Brisson M, Mahon BE, Henao-Restrepo AM
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study Hum Vaccin Immunother. 2019 Jul 16:1-9. doi: 10.1080/21645515.2019.1619402 Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N
Review of the current published evidence for single-dose HPV vaccination 2nd Edition: White Paper RHO Cervical Cancer Library Single-Dose HPV Vaccine Evaluation Consortium
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis The Lancet 2019;DOI: https://doi.org/10.1016/S0140-6736(19)30298-3 Drolet M, Bénard E, Pérez N, Brisson M, the HPV Vaccination Impact Study Group
Global elimination of cervical cancer as a public health problem The Lancet Oncology 2019 Mar;20(3):319-321. doi: 10.1016/S1470-2045(19)30072-5. Brisson M, Drolet M
Model Comparisons of the Effectiveness and Cost-effectiveness of Vaccination: A Systematic Review of the Literature Value in Health 2018 Oct; 21(10):1250-58. doi.org/10.1016/j.jval.2018.03.014 Drolet D, Bénard É, Jit M, Hutubessy R, Brisson M
Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc. 2018 Jun;21(6):e25110. doi: 10.1002/jia2.25110 Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily MC.
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs Vaccine 2018 Aug;36(32A):4806-15. doi.org/10.1016/j.vaccine.2018.01.057 Markowitz LE, Drolet M, Perez N, Jit M, Brisson M
Review of the current published evidence for single-dose HPV vaccination: White Paper RHO Cervical Cancer Library Single-Dose HPV Vaccine Evaluation Consortium
Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14 year old girls against human papillomavirus Int J Cancer. 2018 Jul 15;143(2):317-323. doi: 10.1002/ijc.31321. Jit M, Brisson M.
The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation J Infect Dis 2017Dec5;216(10):1205-09. doi: 10.1093/infdis/jix476. Drolet M, Laprise JF, Brotherton JML, Donovan B, Fairley CK, Ali H, Bénard É, Martin D, Brisson M
Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M Epidemics 2017Dec;21:80-87. doi: 10.1016/j.epidem.2017.08.001.
Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions Am J Epidemiol. 2016 15;184(12):873-883 Malagón T, Lemieux-Mellouki P, Laprise JF, Brisson M
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models Lancet Pub Health 2016;1(1):e8-17 Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C
Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis Lancet Pub Health 2016;1(2):e66-75 Simms KT, Laprise JF, Smith MA, Lew JB, Caruana M, Brisson M, Canfell K
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerg Infect Dis. 2016;22(10):1732-40. doi: 10.3201/eid2210.160675. Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL
Effect of HPV on cervical cancer screening in Alberta. CMAJ. 2016;188(14):1035. Brisson M, Drolet M, Bénard É, Kreimer AR
Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review. PLoS One. 2016;11(9):e0163880. doi: 10.1371/journal.pone.0163880. Gingras G, Guertin MH, Laprise JF, Drolet M, Brisson M
Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis. J Infect Dis. 2016Sep1;214(5):685-8. doi: 10.1093/infdis/jiw227 Laprise JF, Markowitz LE, Chesson HW, Drolet M, Brisson M
Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada Vaccine. 2016Apr7;34(16):1874-80. doi: 10.1016/j.vaccine.2016.02.069. Drolet M, Deeks SL, Kliewer E, Musto G, Lambert P, Brisson M
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines Int J Cancer. 2016Aug1;139(3):510-17. doi: 10.1002/ijc.30063 Brotherton JML, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S
The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine J Infect Dis. 2016Jun1;213(11):1694-1700. doi: 10.1093/infdis/jiw046 HW Chesson, JF Laprise, M Brisson, LE Markowitz
Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior Emerg Infect Dis. 2016;22(1):18-23. doi: 10.3201/eid2201.150791 Baussano I, Lazzarato F, Brisson M, Franceschi S
Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus. Epidemiol Infect. 2016 May;144(7):1490-9. doi: 10.1017/S0950268815002915. Lemieux-Mellouki P, Drolet M, Brisson J, Franco EL, Boily MC, Baussano I, Brisson M
Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States JNCI J Natl Cancer Inst. 2016;108(1) doi: 10.1093/jnci/djv282 Brisson M, Laprise JF, Chesson HW, Drolet M, Malagón T, Boily MC, Markowitz LE
Fewer than three doses of HPV vaccine Lancet Oncol. 2015Sep1;16(9):PE423-E424. DOI: http://dx.doi.org/10.1016/S1470-2045(15)00229-6 Jit M, Laprise JF, Choi YH, Brisson M
Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis AIDS Behav. 2015 Jul;19(7):1338-60 doi: 10.1007/s10461-015-0997-y. Owen BN, Brock PM, Butler AR, Pickles M, Brisson M, Baggaley RF, Boily MC
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis The Lancet ID. 2015;15(5):565-80 Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer h, Beddows S, Brisson J, Brotherton JML, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M
Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model BMJ. 2015;350:g7584 Jit M, Brisson M, Laprise JF, Choi YH
Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):276-85 Malagón T, Drolet M, Boily MC, Laprise JF, Brisson M